ADD-ON TRIAL IN THERAPY-RESISTANT PATIENTS - AN APPROPRIATE METHOD FOR EVALUATING NEW ANTIEPILEPTIC DRUGS

被引：0
|
作者：
BULAU, P [1 ]
机构：
[1] UNIV BONN, NERVENKLIN EPILEPTOL, D-5300 BONN, GERMANY
来源：
ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY | 1988年 / 70卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R318 [生物医学工程];
学科分类号：
0831 ;
摘要：
引用
收藏
页码：P49 / P49
页数：1
相关论文
共 50 条
  • [31] Visual contrast sensitivity in carbamazepine-resistant epileptic patients receiving vigabatrin as add-on therapy
    Sartucci, F
    Massetani, R
    Galli, R
    Bonanni, E
    Tognoni, G
    Milani, S
    Iudice, A
    Murri, L
    JOURNAL OF EPILEPSY, 1997, 10 (01): : 7 - 11
  • [32] Clobazam as an Add-on Therapy of Patients with Drug-resistant Epilepsy: Experience of a Tertiary Epilepsy Center
    Sirin, Nermin Goerkem
    Baykan, Betuel
    Bebek, Nerses
    EPILEPSI, 2020, 26 (03): : 155 - 160
  • [33] A Randomized Controlled Double-Masked Trial of Albuterol Add-on Therapy in Patients With Multiple Sclerosis
    Khoury, Samia J.
    Healy, Brian C.
    Kivisakk, Pia
    Viglietta, Vissia
    Egorova, Svetlana
    Guttmann, Charles R. G.
    Wedgwood, Josiah F.
    Hafler, David A.
    Weiner, Howard L.
    Buckle, Guy
    Cook, Sandra
    Reddy, Susheel
    ARCHIVES OF NEUROLOGY, 2010, 67 (09) : 1055 - 1061
  • [34] Tolerability of clobazam as add-on therapy in patients aged 50 years and older with drug-resistant epilepsy
    Elanagan Nagarajan
    Timothy M. Lynch
    Bridget Frawley
    Marjorie E. Bunch
    Neurological Sciences, 2023, 44 : 2883 - 2888
  • [35] Dapagliflozin as add-on therapy in Asian patients with type 2 diabetes inadequately controlled on insulin with or without oral antihyperglycemic drugs: A randomized controlled trial
    Yang, Wenying
    Ma, Jianhua
    Li, Yiming
    Li, Yanbing
    Zhou, Zhiguang
    Kim, Jae Hyeon
    Zhao, June
    Ptaszynska, Agata
    JOURNAL OF DIABETES, 2018, 10 (07) : 589 - 599
  • [36] Tolerability of clobazam as add-on therapy in patients aged 50 years and older with drug-resistant epilepsy
    Nagarajan, Elanagan
    Lynch, Timothy M.
    Frawley, Bridget
    Bunch, Marjorie E.
    NEUROLOGICAL SCIENCES, 2023, 44 (08) : 2883 - 2888
  • [37] Pregabalin does not show pharmacokinetic drug-drug interactions with commonly used antiepileptic drugs when used as add-on therapy for partial epilepsy
    Bockbrader, H
    Wesche, D
    JOURNAL OF NEUROLOGY, 2004, 251 : 9 - 9
  • [38] Clinical and EEG effects of lamotrigine as add-on therapy in adults with typical Lennox-Gastaut syndrome unsatisfactorily controlled by current antiepileptic drugs.
    Foletti, G
    Delisle, MC
    Chardon, F
    Volanschi, D
    EPILEPSIA, 1999, 40 : 166 - 166
  • [39] Substitution has better efficacy than add-on therapy for patients with focal epilepsy after their first antiepileptic drug treatments fail
    Wang, Xiao
    He, Ruqian
    Zeng, Qingyi
    Wang, Yi
    Zhu, Pan
    Bao, Yixin
    Du, Yanru
    Shen, Jinzan
    Zheng, Rongyuan
    Xu, Huiqin
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2019, 64 : 23 - 28
  • [40] DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL WITH FLUNARIZINE IN THERAPY-RESISTANT EPILEPTIC PATIENTS
    FROSCHER, W
    BULAU, P
    BURR, W
    PENIN, H
    RAO, ML
    DEBEUKELAAR, F
    CLINICAL NEUROPHARMACOLOGY, 1988, 11 (03) : 232 - 240
12345